1467605-60-2

Basic information

• Product Name: methyl-3-((7-methoxy-2,3-dihydrobenzo[f][1,4]thiazepin-4(5H)-yl)methyl)benzoate
• Synonyms: methyl-3-((7-methoxy-2,3-dihydrobenzo[f][1,4]thiazepin-4(5H)-yl)methyl)benzoate
• CAS NO: 1467605-60-2
• Molecular Weight: 343.447
• Mol File: 1467605-60-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: methyl-3-((7-methoxy-2,3-dihydrobenzo[f][1,4]thiazepin-4(5H)-yl)methyl)benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl-3-((7-methoxy-2,3-dihydrobenzo[f][1,4]thiazepin-4(5H)-yl)methyl)benzoate(1467605-60-2)
• EPA Substance Registry System: methyl-3-((7-methoxy-2,3-dihydrobenzo[f][1,4]thiazepin-4(5H)-yl)methyl)benzoate(1467605-60-2)

Safety Data

• Hazardous Substances Data: 1467605-60-2(Hazardous Substances Data)

Upstream product

• 145903-31-7 7-methoxy-2,3,4,5-tetrahydrobenzo[f][1,4]thiazepine 
• 1186400-77-0 benzyl 7-methoxy-2,3-dihydrobenzo[f][1,4]-thiazepine-4(5H)-carboxylate 
• 1186400-76-9 benzyl-2-(4-methoxyphenylthio)ethylcarbamate 
• 696-63-9 4-Methoxybenzenethiol 
• 36155-36-9 2-<(4-methoxyphenyl)thio>-1-aminoethane 

Downstream Products

• 1467605-68-0 3-((7-methoxy-2,3-dihydrobenzo[f][1,4]thiazepin-4(5H)-yl)methyl)benzoic acid 

Relevant articles and documents

Agents for treating disorders involving modulation of ryanodine receptors

The present invention relates to 1,4-benzothiazepine derivatives and their use to treat conditions, disorders and diseases associated with ryanodine receptors (RyRs) that regulate calcium channel functioning in cells. The invention also discloses pharmaceutical compositions comprising the compounds and uses thereof to treat diseases and conditions associated with RyRs, in particular cardiac, musculoskeletal and central nervous system (CNS) disorders.